Provided by Tiger Trade Technology Pte. Ltd.

AKESO

90.300
-3.300-3.53%
Volume:11.03M
Turnover:1.00B
Market Cap:83.17B
PE:-62.66
High:92.700
Open:92.450
Low:90.250
Close:93.600
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.82
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.441
ROE:-13.59%
ROA:-4.57%
PB:8.38
PE(LYR):-62.66
PS:20.62

Loading ...

CORRECTED-Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial (May 31)

Reuters
·
May 31

Stock Track | AKESO Soars 5.07% Intraday as Ivonescimab Data Selected for ASCO Plenary Presentation

Stock Track
·
May 29

Movement Alert|Akeso Bio Rises 3.99% in Regular Trading, ASCO Plenary Session Oral Presentation of Ivonescimab OS Data Set to Unveil

Market Focus
·
May 29

Stock Track | AKESO Plummets 5.03% Intraday on Disappointing Ivonescimab Phase III Interim Results

Stock Track
·
May 28

Hong Kong Stock Connect Biotech Sector Extends Over 8-Month Slump, Key ETF Hits Record Low

Deep News
·
May 28

Movement Alert|Akeso Bio Falls 3.13% in Regular Trading, Ivonescimab Global Phase III Interim Analysis Missing Endpoint Continues to Weigh on Valuation

Market Focus
·
May 28

Movement Alert|Akeso Inc Rises 3.03% in Regular Trading, ASCO Plenary Session Oral Presentation Approaching as Key Catalyst

Market Focus
·
May 27

Akeso says Phase 3 HARMONi-6 overall survival data for ivonescimab in first-line squamous NSCLC lands ASCO plenary slot

Reuters
·
May 26

BUZZ-J&T Global Express leads gain in newcomers to Hang Seng Index

Reuters
·
May 26

Movement Alert|Akeso Bio Falls 3.09% in Regular Trading, Ivonescimab Global Phase III Interim Miss Continues to Weigh on Valuation

Market Focus
·
May 26

Hang Seng Index Quarterly Review Boosts Industrial and Healthcare Sector Coverage; Six Stocks May Enter Southbound Trading

Stock News
·
May 25

Hang Seng Index Quarterly Review Results Announced: New Additions Include J&T Express, BeiGene, and CHALCO

Deep News
·
May 22

Zhipu and MiniMax Poised for Inclusion in Hang Seng Tech Index

Deep News
·
May 22

A Look At Akeso (SEHK:9926) Valuation After New Cadonilimab Approval In Colorectal Cancer

Simply Wall St.
·
May 22

Stock Track | AKESO Plummets 5.08% Intraday on Disappointing Ivonescimab Phase III Trial Results

Stock Track
·
May 22

Movement Alert|Akeso Bio Falls 3.75% in Regular Trading, Ivonescimab Global Phase III Interim Analysis Missing Endpoint Continues to Weigh on Valuation

Market Focus
·
May 22

Innovative Drug Sector Rebound Ahead of ASCO Conference: Key ETFs Gain Momentum

Deep News
·
May 21

AKESO Shares Surge Over 7% in Morning Session on Clinical Approval for Cadonilimab in Colon Cancer

Stock News
·
May 21

Stock Track | AKESO Soars 6.61% Intraday on ASCO Abstract Embargo Lifting and Biotech Sector Strength

Stock Track
·
May 21

Movement Alert|Akeso Inc Rises 3.22% in Regular Trading, ASCO Abstract Embargo Lifting Combined with Biotech Sector Rally

Market Focus
·
May 21